COVID-19: a cause of recurrent Graves' hyperthyroidism?
作者信息
Jiménez-Blanco S, Pla-Peris B, Marazuela M
机构信息
Department of Endocrinology and Nutrition, University Hospital of La Princesa, Madrid, Spain.
Department of Endocrinology and Nutrition, Hospital Arnau de Vilanova, Valencia, Spain.
出版信息
J Endocrinol Invest. 2021 Feb;44(2):387-388. doi: 10.1007/s40618-020-01440-0. Epub 2020 Oct 6.
Abstract
摘要
相似文献
1
COVID-19: a cause of recurrent Graves' hyperthyroidism?新型冠状病毒肺炎：格雷夫斯病复发性甲状腺功能亢进的一个病因？
J Endocrinol Invest. 2021 Feb;44(2):387-388. doi: 10.1007/s40618-020-01440-0. Epub 2020 Oct 6.
2
SARS-CoV-2 vaccination related hyperthyroidism of Graves' disease.严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）疫苗接种相关的格雷夫斯病甲亢
J Formos Med Assoc. 2022 Sep;121(9):1881-1882. doi: 10.1016/j.jfma.2022.02.010. Epub 2022 Feb 17.
3
Aggravation of hyperthyroidism after heterologous prime-boost immunization with inactivated and adenovirus-vectored SARS-CoV-2 vaccine in a patient with Graves' disease.1例格雷夫斯病患者在接受灭活和腺病毒载体新冠病毒疫苗的异源初免-加强免疫后甲亢加重
Endocrine. 2021 Nov;74(2):226-227. doi: 10.1007/s12020-021-02879-8. Epub 2021 Sep 17.
4
SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves' disease after COVID-19.严重急性呼吸综合征冠状病毒2引发自身免疫性疾病：两例新冠病毒感染后格雷夫斯病病例报告
J Endocrinol Invest. 2020 Oct;43(10):1527-1528. doi: 10.1007/s40618-020-01366-7. Epub 2020 Jul 19.
5
Outcome of very long-term treatment with antithyroid drugs in Graves' hyperthyroidism associated with Graves' orbitopathy.Graves 病伴 Graves 眼病甲状腺功能亢进症患者长期抗甲状腺药物治疗的转归。
Thyroid. 2011 Mar;21(3):279-83. doi: 10.1089/thy.2010.0181. Epub 2010 Dec 29.
6
Management of recurrent hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.甲状腺次全切除术后格雷夫斯病患者复发性甲状腺功能亢进症的管理。
J Endocrinol Invest. 1995 Jun;18(6):415-9. doi: 10.1007/BF03349738.
7
Graves' disease following SARS-CoV-2 vaccination.新型冠状病毒疫苗接种后发生的格雷夫斯病。
Endocrine. 2021 Dec;74(3):473-474. doi: 10.1007/s12020-021-02902-y. Epub 2021 Oct 14.
8
A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor.一种通过肌肉注射表达促甲状腺激素受体的腺病毒构建的格雷夫斯甲亢新型小鼠模型。
J Immunol. 2002 Mar 15;168(6):2789-94. doi: 10.4049/jimmunol.168.6.2789.
9
Management of Graves' hyperthyroidism and orbitopathy in time of COVID-19 pandemic.2019冠状病毒病大流行期间格雷夫斯病甲亢和眼眶病的管理
J Endocrinol Invest. 2020 Aug;43(8):1149-1151. doi: 10.1007/s40618-020-01293-7. Epub 2020 May 21.
10
Human T-lymphotropic virus type I-associated uveitis in patients with Graves' disease treated with methylmercaptoimidazole.用甲巯咪唑治疗的格雷夫斯病患者中的I型人类嗜T淋巴细胞病毒相关性葡萄膜炎。
J Clin Endocrinol Metab. 1995 Jun;80(6):1904-7. doi: 10.1210/jcem.80.6.7775639.
引用本文的文献
1
New-Onset Graves' Disease Induced by COVID-19: A Case Report and Literature Review.COVID-19诱发的新发格雷夫斯病：一例报告及文献综述
Cureus. 2024 Nov 6;16(11):e73122. doi: 10.7759/cureus.73122. eCollection 2024 Nov.
2
Hypophysitis in COVID-19: a systematic review.新型冠状病毒肺炎中的垂体炎：一项系统综述
Pituitary. 2024 Dec;27(6):874-888. doi: 10.1007/s11102-024-01462-4. Epub 2024 Oct 15.
3
New-onset autoimmune thyroid disease following COVID-19.新型冠状病毒肺炎（COVID-19）后新发自身免疫性甲状腺疾病
Asia Pac Allergy. 2024 Aug;14(3):151. doi: 10.5415/apallergy.0000000000000145. Epub 2024 May 30.
4
Thyroid Stimulating Hormone as a Possible Additional COVID-19 Outcome Marker.促甲状腺激素可能成为 COVID-19 的另一个预后标志物。
Medicina (Kaunas). 2024 Feb 12;60(2):314. doi: 10.3390/medicina60020314.
5
Development of autoimmune thyroid disease after COVID-19 infection: case report.新冠病毒感染后自身免疫性甲状腺疾病的发生：病例报告
Front Med (Lausanne). 2024 Feb 7;11:1303855. doi: 10.3389/fmed.2024.1303855. eCollection 2024.
6
Impact of COVID-19 on thyroid gland functions with reference to Graves' disease: A systematic review.2019冠状病毒病对甲状腺功能的影响及格雷夫斯病相关研究：一项系统综述
J Family Med Prim Care. 2023 Sep;12(9):1784-1789. doi: 10.4103/jfmpc.jfmpc_2246_22. Epub 2023 Sep 30.
7
SARS-CoV-2 Affects Thyroid and Adrenal Glands: An F-FDG PET/CT Study.严重急性呼吸综合征冠状病毒2感染甲状腺和肾上腺：一项氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描研究
Biomedicines. 2023 Oct 26;11(11):2899. doi: 10.3390/biomedicines11112899.
8
Thyroid Autoimmunity and SARS-CoV-2 Infection.甲状腺自身免疫与2019冠状病毒病感染
J Clin Med. 2023 Oct 5;12(19):6365. doi: 10.3390/jcm12196365.
9
Thyrotoxicosis after COVID-19 Infection with a Delay in Graves' Disease Antibody Positivity.新冠病毒感染后出现甲状腺毒症且格雷夫斯病抗体阳性延迟出现
Case Rep Endocrinol. 2023 Apr 8;2023:8402725. doi: 10.1155/2023/8402725. eCollection 2023.
10
SARS-CoV-2 infection and its effects on the endocrine system.SARS-CoV-2 感染及其对内分泌系统的影响。
Best Pract Res Clin Endocrinol Metab. 2023 Jul;37(4):101761. doi: 10.1016/j.beem.2023.101761. Epub 2023 Mar 5.
本文引用的文献
1
Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease.格雷夫斯病患者血清白细胞介素-6（IL-6）和可溶性IL-6受体浓度升高。
J Clin Endocrinol Metab. 1996 Aug;81(8):2976-9. doi: 10.1210/jcem.81.8.8768861.
Zotero 插件